3-(2,4-DIFLUOROPHENYL)PROP-2-YNOIC ACID, 95.0%, 100mg

1,4-Dibromonaphthalene, 98.0%, 1g

4-(4-Chloro-6-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazin-2-yl)morpholine, 95.0%, 5g

1.1-bis(methylthio)-2-nitroethylene, 98.0%, 1g

4-(3-(BROMOMETHYL)PHENYL)MORPHOLINE, 95%, 250mg

Methyl 4-amino-3-(butylamino)benzoate, 95%, 5g

[1-(adamantan-1-yl)ethyl]urea, 98%, 500mg

3-Chloro-p-cresol>98.0%(GC)5g

1-Decanol>98.0%(GC)500mL

(2S,4R)-1-((S)-2-((Cyclopentyloxy)carbonyl)-3,3-dimethylbutanoyl)-4-hydroxypyrrolidine-2-carboxylic acid, 95.0%, 1g

1-(4-bromophenyl)-1,3-diazinane-2,4,6-trione, 95.0%, 1g

(6Z,9Z,28Z,31Z)-HEPTATRIACONTA-6,9,28,31-TETRAEN-19-YL 4-(DIMETHYLAMINO)BUTANOATE, 95%, 1g

Direct displacement pipette Transferpettor digital, 5 to 25 µl, 1 piece